Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
Holders of 5% or more of ACHV
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Achieve Life Sciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| TPG GP A, LLC | 13D | 12.60%13.8M shares | New | Apr 24, 20261 filing | Apr 24, 2026 | SEC |
| venBio Global Strategic Fund V, L.P. | 13D | 9.99%10.7M shares | New | Apr 27, 20261 filing | Apr 27, 2026 | SEC |
| Paradigm Biocapital Advisors LP | 13G | 9.20%9.90M shares | New | Apr 24, 20261 filing | Apr 24, 2026 | SEC |
| Frazier Life Sciences Public Fund, L.P. | 13G | 6.50%6.63M shares | New | Apr 24, 20261 filing | Apr 24, 2026 | SEC |
| Franklin Resources Inc | 13G/A | 6.20%6.37M shares | −5.30 ppfrom 11.50% | Oct 31, 20245 filings | May 7, 2026 | SEC |
| Alyeska Investment Group, L.P. | 13G/A | 5.60%2.98M shares | −4.30 ppfrom 9.90% | Aug 14, 20252 filings | Nov 14, 2025 | SEC |
| Venrock Healthcare Capital Partners III, L.P. | 13G | 5.20%5.50M shares | New | Apr 24, 20261 filing | Apr 24, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
15 Schedule 13D and 13G filings on Achieve Life Sciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 7, 202612:25 PM ET | Franklin Resources Incand 3 others | 13G/A | 6.20%6.37M shares | −5.30 ppfrom 11.50% | Apr 30, 2026 | SEC |
| Apr 27, 20265:28 PM ET | venBio Global Strategic Fund V, L.P.and 1 other | 13D | 9.99%10.7M shares | New | Apr 15, 2026 | SEC |
| Apr 24, 20268:12 PM ET | Paradigm Biocapital Advisors LPand 3 others | 13G | 9.20%9.90M shares | New | Apr 17, 2026 | SEC |
| Apr 24, 20265:03 PM ET | TPG GP A, LLCand 2 others | 13D | 12.60%13.8M shares | New | Apr 17, 2025 | SEC |
| Apr 24, 20264:57 PM ET | Frazier Life Sciences Public Fund, L.P.and 8 others | 13G | 6.50%6.63M shares | New | Apr 17, 2026 | SEC |
| Apr 24, 20264:12 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G | 5.20%5.50M shares | New | Apr 17, 2026 | SEC |
| Jan 29, 202611:13 AM ET | Franklin Resources Incand 3 others | 13G/A | 11.50%6.37M shares | −4.50 ppfrom 16.00% | Dec 31, 2025 | SEC |
| Nov 14, 20258:05 PM ET | Alyeska Investment Group, L.P.and 2 others | 13G/A | 5.60%2.98M shares | −4.30 ppfrom 9.90% | Sep 30, 2025 | SEC |
| Nov 14, 202510:54 AM ET | Contrarian Alpha, LPand 5 others | 13G/A | 4.90%2.53M shares | –Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20255:26 PM ET | Alyeska Investment Group, L.P.and 2 others | 13G | 9.90%4.92M shares | New | Jun 30, 2025 | SEC |
| Aug 5, 202510:54 AM ET | Franklin Resources Incand 3 others | 13G/A | 16.00%8.64M shares | +3.40 ppfrom 12.60% | Jun 30, 2025 | SEC |
| Jul 16, 20257:02 PM ET | BlackRock, Inc. | 13G/A | 0.60%314.7K shares | –Below 5% | Jun 30, 2025 | SEC |
| May 9, 20251:01 PM ET | Franklin Resources Incand 3 others | 13G/A | 12.60%4.64M shares | −4.00 ppfrom 16.60% | Mar 31, 2025 | SEC |
| Apr 30, 202510:59 AM ET | Vanguard Group Inc | 13G/A | 4.95%1.72M shares | –Below 5% | Mar 31, 2025 | SEC |
| Oct 31, 202412:38 PM ET | Franklin Resources Incand 3 others | 13G/A | 16.60%6.05M shares | – | Sep 30, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Achieve Life Sciences, Inc. shares.
No Form 144 notices for Achieve Life Sciences, Inc. are on file.